EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
Year Ended December 31,
------------------------------
1996 1997
------------ ------------
Net (loss) ($2,890,000) ($3,252,000)
Add cumulative preferred dividend (307,000) (234,000)
------------ ------------
NET (LOSS) USED FOR COMPUTATION ($3,197,000) ($3,486,000)
------------ ------------
------------ ------------
Weighted average number of common shares
outstanding 7,640,000 8,268,000
------------ ------------
------------ ------------
Net (loss) per common share ($0.42) ($0.42)
------------ ------------
------------ ------------
11